Skip to main content
Vaccine Development
Research Centers Center for Vaccine Development and Global Health (CVD)ResearchVaccine DevelopmentPatents

Patents

Patents and Intellectual Property

Our researchers have developed technology resulting in 94 U.S. patents for vaccines, diagnostics, and drug delivery systems.

Recent examples include:

9,050,283: Broad spectrum vaccine against non-typhoidal Salmonella, 2016.

  • Inventors: Myron M. Levine, Raphael Simon, James Galen, and Sharon Tennant

9,446,113: Bacterial live vector vaccines expressing chromosomally-integrated foreign antigens, 2016.

  • Inventors: James E. Galen, Jin-Yuan Wang

Patent application PCT/US2015/051032: Broad spectrum conjugate vaccine to prevent Klebsiella pneumoniae and Pseudomonas aeruginosa infections, 2016.

  • Inventors: Raphael Simon, Alan S. Cross, and Sharon M. Tennant

9,011,871: Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease, 2015.

  • Inventors: Myron M. Levine, James Galen, Raphael Simon, and Sharon Tennant

9,051,574: Antigen Export Technology Using Non-hemolytic Versions of ClyA, 2015.

  • Inventors: James E. Galen, Yuansha Chen

9,200,258: Multicellular Organotypic Model of Intestinal Mucosa, 2015.

  • Inventors: Rosangela Mezghanni, Alessio Fasano, and Marcelo B Sztein

Provisional patent application number 62/146,545: Compositions and methods for producing bacterial conjugate vaccines.

  • Inventors: Raphael Simon, Myron M. Levine, and Sharon M. Tennant

For further information concerning licensing CVD intellectual technology, please view the website of the University of Maryland UM Ventures.